These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 25449994)
1. Pharmacokinetics of dolutegravir when administered with mineral supplements in healthy adult subjects. Song I; Borland J; Arya N; Wynne B; Piscitelli S J Clin Pharmacol; 2015 May; 55(5):490-6. PubMed ID: 25449994 [TBL] [Abstract][Full Text] [Related]
2. Effect of food on the pharmacokinetics of the integrase inhibitor dolutegravir. Song I; Borland J; Chen S; Patel P; Wajima T; Peppercorn A; Piscitelli SC Antimicrob Agents Chemother; 2012 Mar; 56(3):1627-9. PubMed ID: 22183173 [TBL] [Abstract][Full Text] [Related]
3. Relative bioavailability of a paediatric granule formulation of the HIV integrase inhibitor dolutegravir in healthy adult subjects. Patel P; Song I; Borland J; Chen S; Peppercorn A; Wajima T; Funaki T; Fujita N; Hughes J; Piscitelli S Antivir Ther; 2014; 19(3):229-33. PubMed ID: 24275098 [TBL] [Abstract][Full Text] [Related]
4. A Two-Way Steady-State Pharmacokinetic Interaction Study of Doravirine (MK-1439) and Dolutegravir. Anderson MS; Khalilieh S; Yee KL; Liu R; Fan L; Rizk ML; Shah V; Hussaini A; Song I; Ross LL; Butterton JR Clin Pharmacokinet; 2017 Jun; 56(6):661-669. PubMed ID: 27699622 [TBL] [Abstract][Full Text] [Related]
5. Effect of carbamazepine on dolutegravir pharmacokinetics and dosing recommendation. Song I; Weller S; Patel J; Borland J; Wynne B; Choukour M; Jerva F; Piscitelli S Eur J Clin Pharmacol; 2016 Jun; 72(6):665-70. PubMed ID: 26898568 [TBL] [Abstract][Full Text] [Related]
6. Bioequivalence and Food Effect Assessment of 2 Fixed-Dose Combination Formulations of Dolutegravir and Lamivudine. Dumitrescu TP; Peddiraju K; Fu C; Bakshi K; Yu S; Zhang Z; Tenorio AR; Spancake C; Joshi S; Wolstenholme A; Adkison K Clin Pharmacol Drug Dev; 2020 Feb; 9(2):189-202. PubMed ID: 31724343 [TBL] [Abstract][Full Text] [Related]
7. Effects of Food and Calcium Carbonate on the Pharmacokinetics of Lusutrombopag, a Novel Thrombopoietin Receptor Agonist. Katsube T; Wajima T; Fukuhara T; Kano T Clin Ther; 2019 Sep; 41(9):1747-1754.e2. PubMed ID: 31303281 [TBL] [Abstract][Full Text] [Related]
8. Population pharmacokinetics of dolutegravir in HIV-infected treatment-naive patients. Zhang J; Hayes S; Sadler BM; Minto I; Brandt J; Piscitelli S; Min S; Song IH Br J Clin Pharmacol; 2015 Sep; 80(3):502-14. PubMed ID: 25819132 [TBL] [Abstract][Full Text] [Related]
9. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions. Chen C; Bujanover S; Kareht S; Rapoport AM Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369 [TBL] [Abstract][Full Text] [Related]
10. Effect of a single supratherapeutic dose of dolutegravir on cardiac repolarization. Chen S; Min SS; Peppercorn A; Borland J; Lou Y; Song I; Fujiwara T; Piscitelli SC Pharmacotherapy; 2012 Apr; 32(4):333-9. PubMed ID: 22422361 [TBL] [Abstract][Full Text] [Related]
11. A randomized, phase I, 3-way crossover study to examine the effects of food on the pharmacokinetics of single doses of 400 mg posaconazole oral suspension in healthy male Taiwanese subjects. Lin TY; Yang MH; Chang FY Ther Drug Monit; 2013 Apr; 35(2):223-7. PubMed ID: 23503449 [TBL] [Abstract][Full Text] [Related]
12. Effects of an Al(3+)- and Mg(2+)-containing antacid, ferrous sulfate, and calcium carbonate on the absorption of nemonoxacin (TG-873870) in healthy Chinese volunteers. Zhang YF; Dai XJ; Wang T; Chen XY; Liang L; Qiao H; Tsai CY; Chang LW; Huang PT; Hsu CY; Chang YT; Tsai CE; Zhong DF Acta Pharmacol Sin; 2014 Dec; 35(12):1586-92. PubMed ID: 25327812 [TBL] [Abstract][Full Text] [Related]
13. Effects of iron supplements on the oral bioavailability of moxifloxacin, a novel 8-methoxyfluoroquinolone, in humans. Stass H; Kubitza D Clin Pharmacokinet; 2001; 40 Suppl 1():57-62. PubMed ID: 11352443 [TBL] [Abstract][Full Text] [Related]
14. The pharmacokinetics of cinacalcet are unaffected following consumption of high- and low-fat meals. Padhi D; Salfi M; Harris RZ Am J Ther; 2007; 14(3):235-40. PubMed ID: 17515696 [TBL] [Abstract][Full Text] [Related]
15. No clinically significant pharmacokinetic interactions between dolutegravir and daclatasvir in healthy adult subjects. Ross LL; Song IH; Arya N; Choukour M; Zong J; Huang SP; Eley T; Wynne B; Buchanan AM BMC Infect Dis; 2016 Jul; 16():347. PubMed ID: 27450277 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of the impact of multivalent metal ions on the permeation behavior of Dolutegravir sodium. Grießinger JA; Hauptstein S; Laffleur F; Netsomboon K; Bernkop-Schnürch A Drug Dev Ind Pharm; 2016; 42(7):1118-26. PubMed ID: 26552713 [TBL] [Abstract][Full Text] [Related]
17. The Effect of Dolutegravir on the Pharmacokinetics of Metformin in Healthy Subjects. Song IH; Zong J; Borland J; Jerva F; Wynne B; Zamek-Gliszczynski MJ; Humphreys JE; Bowers GD; Choukour M J Acquir Immune Defic Syndr; 2016 Aug; 72(4):400-7. PubMed ID: 26974526 [TBL] [Abstract][Full Text] [Related]
18. Effect of food on the oral bioavailability of didanosine from encapsulated enteric-coated beads. Damle BD; Yan JH; Behr D; O'Mara E; Nichola P; Kaul S; Knupp C J Clin Pharmacol; 2002 Apr; 42(4):419-27. PubMed ID: 11936567 [TBL] [Abstract][Full Text] [Related]
19. Effects of food intake on the pharmacokinetic properties of dalcetrapib: findings from three phase I, single-dose crossover studies in healthy volunteers. Derks M; Kawamura H; Abt M; Meneses-Lorente G; Phelan M; Ishikawa T Clin Ther; 2011 Jun; 33(6):754-65. PubMed ID: 21704240 [TBL] [Abstract][Full Text] [Related]
20. Effects of boceprevir and telaprevir on the pharmacokinetics of dolutegravir. Johnson M; Borland J; Chen S; Savina P; Wynne B; Piscitelli S Br J Clin Pharmacol; 2014 Nov; 78(5):1043-9. PubMed ID: 24838177 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]